Pfizer appears to be like past COVID as Paxlovid price sparks swing to quarterly loss
Paxlovid, Pfizer’s anti-viral drugs to regard the coronavirus illness (COVID-19), is displayed on this image representation taken October 7, 2022. REUTERS/Wolfgang Rattay/Representation/Record Photograph Achieve Licensing RightsOct 31 (Reuters) – Pfizer (PFE.N) on
